These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9587508)

  • 21. Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.
    Coverdale SA; Khan MH; Byth K; Lin R; Weltman M; George J; Samarasinghe D; Liddle C; Kench JG; Crewe E; Farrell GC
    Am J Gastroenterol; 2004 Apr; 99(4):636-44. PubMed ID: 15089895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A; Yong JF; Zulkifli HI; Jamal R
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Hosaka T; Kobayashi M; Kumada H
    J Gastroenterol; 2004; 39(5):455-60. PubMed ID: 15175944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host factors and failure of interferon-alpha treatment in hepatitis C virus.
    Gao B; Hong F; Radaeva S
    Hepatology; 2004 Apr; 39(4):880-90. PubMed ID: 15057887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load].
    Parolin MB; Lacerda MA; Lopes RW
    Arq Gastroenterol; 1999; 36(2):63-7. PubMed ID: 10511883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular tools for the treatment of hepatitis C.
    Pawlotsky JM; Gretch DR
    Antivir Ther; 1998; 3(Suppl 3):45-55. PubMed ID: 10726055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis C treatment without liver biopsy].
    Siboni A
    Ugeskr Laeger; 2002 Mar; 164(11):1522-3; discussion 1523-4. PubMed ID: 11924484
    [No Abstract]   [Full Text] [Related]  

  • 29. Interferon treatment of HCV positive cirrhotic patients.
    Idilman R; Colantoni A; De Maria N; Van Thiel DH
    Hepatogastroenterology; 1998; 45(20):340-4. PubMed ID: 9638403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
    Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.
    Pojoga C; Dumitraşcu DL; Pascu O; Grigorescu M
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pegylated interferon-alpha for the treatment of chronic hepatitis C].
    Weis NM; Krarup HB; Skinhøj P
    Ugeskr Laeger; 2003 Oct; 165(44):4211-5. PubMed ID: 14621552
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of high-dose interferon in the treatment of chronic hepatitis C.
    Shiffman ML
    Semin Liver Dis; 1999; 19 Suppl 1():25-33. PubMed ID: 10349690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of alpha 2b versus lymphoblastoid interferon in treatment of chronic hepatitis C. A randomized trial.
    González Sánchez M; Palacios A; Caballero T; Torres Fernández-Piñar C; Bellot V; Ruiz Extremera A; Salmerón J
    Rev Esp Enferm Dig; 1998 Aug; 90(8):553-62. PubMed ID: 9780788
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of chronic hepatitis C.
    Pol S; Bréchot C
    Acta Gastroenterol Belg; 1999; 62(1):32-9; discussion 39-40. PubMed ID: 10333597
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon alfa for chronic hepatitis C infection.
    Delgado Fernández M; Zambrana García JL; Díez García F
    Lancet; 1999 Feb; 353(9151):499-500. PubMed ID: 9989747
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon in wonderland.
    Koretz RL
    Gastroenterology; 1998 Oct; 115(4):1027-9. PubMed ID: 9786731
    [No Abstract]   [Full Text] [Related]  

  • 40. [When should one treat a child with chronic hepatitis C with interferon?].
    Maggiore G; Caprai S
    Arch Pediatr; 1999; 6 Suppl 2():174s-175s. PubMed ID: 10370470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.